证券记录 · 已归档季度
GOSS
Gossamer Bio, Inc. · Healthcare · Biotechnology
12被追踪持有人
0Δ持有人
44.92M持有股份
$55.25M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +6.2% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 61 | -10 | 149.99M | $24.69M | +3 | −13 |
| Q1 2026 | 73 | -3 | 96.26M | $32.15M | +6 | −9 |
| Q4 2025 | 76 | -1 | 88.23M | $273.50M | — | −1 |
| Q3 2025 | 18 | +3 | 53.94M | $141.87M | +3 | — |
| Q2 2025 | 12 | 0 | 44.92M | $55.25M | +1 | −1 |
| Q1 2025 | 9 | +1 | 11.42M | $12.56M | +1 | — |
| Q4 2024 | 8 | 0 | 11.95M | $10.80M | — | — |
| Q3 2024 | 7 | 0 | 18.68M | $18.44M | — | — |
| Q2 2024 | 7 | — | 23.16M | $20.86M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 12.14M | — | $14.94M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 12.14M | — | $14.94M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 12.14M | — | $14.94M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 12.14M | — | $14.94M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 12.14M | — | $14.94M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 12.14M | — | $14.94M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | The Vanguard Group ✦ (被动) | 11.41M | — | $14.04M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | The Vanguard Group ✦ (被动) | 11.41M | — | $14.04M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | The Vanguard Group ✦ (被动) | 11.41M | — | $14.04M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 7.32M | — | $9.00M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 7.32M | — | $9.00M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (被动) | 4.56M | +100.5% | $5.60M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 13 | Geode Capital Management ✦ (被动) | 4.56M | +100.5% | $5.60M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 2.73M | +74.1% | $3.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (被动) | 2.48M | +181.1% | $3.05M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 1.75M | +36.8% | $2.15M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Arrowstreet Capital ✦ | 1.12M | +39.1% | $1.38M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Citadel Advisors ✦ | 767.56K | +389.1% | $944,100 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Citadel Advisors ✦ | 767.56K | +389.1% | $944,100 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Millennium Management ✦ | 496.25K | -81.5% | $610,385 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 95.29K | +47.1% | $118,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 56.81K | 新增 | $69,874 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| D. E. Shaw & Co. | $69,874 | 0.0% |
已清仓
| Marshall Wace | $1.89M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1 持有人, 2.17M 股份, $845,282 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据